Diploma (LON:DPLM - Get Free Report) issued its earnings results on Wednesday. The company reported GBX 80.20 ($1.07) earnings per share for the quarter, Digital Look Earnings reports. Diploma had a return on equity of 13.18% and a net margin of 9.25%.
Diploma Trading Up 0.0%
LON DPLM traded up GBX 2 ($0.03) on Wednesday, reaching GBX 4,862 ($65.11). The stock had a trading volume of 11,814,022 shares, compared to its average volume of 570,652. The firm has a market capitalization of £6.49 billion, a price-to-earnings ratio of 55.89, a P/E/G ratio of 2.82 and a beta of 0.75. The company has a quick ratio of 0.80, a current ratio of 2.17 and a debt-to-equity ratio of 62.17. Diploma has a 12-month low of GBX 3,532 ($47.30) and a 12-month high of GBX 5,025 ($67.30). The stock has a fifty day moving average price of GBX 3,949.28 and a two-hundred day moving average price of GBX 4,253.28.
Insider Buying and Selling at Diploma
In other Diploma news, insider Ian El-Mokadem bought 500 shares of the firm's stock in a transaction dated Monday, March 24th. The stock was acquired at an average price of GBX 3,948 ($52.87) per share, for a total transaction of £19,740 ($26,436.32). Also, insider David S. Lowden bought 750 shares of the firm's stock in a transaction dated Friday, March 21st. The shares were acquired at an average price of GBX 3,928 ($52.60) per share, with a total value of £29,460 ($39,453.60). 0.52% of the stock is owned by corporate insiders.
About Diploma
(
Get Free Report)
Diploma PLC, together with its subsidiaries, supplies specialized technical products and services in the United Kingdom, Continental Europe, North America, and internationally. It operates through three business sectors: Life Sciences, Seals, and Controls. The Life Sciences sector supplies technology-enabled products used in surgical procedures in operating theatres and endoscopy; testing equipment and services for clinical laboratories; and bio-pharma, food safety and testing, and other research-oriented products.
Read More
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Diploma, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Diploma wasn't on the list.
While Diploma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
